Northpointe Capital’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-213,554
Closed -$3.49M 199
2017
Q4
$3.49M Sell
213,554
-22,852
-10% -$442K 0.39% 109
2017
Q3
$5.4M Buy
+236,406
New +$5.04M 0.58% 62
2016
Q2
Sell
-5,504
Closed -$159K 254
2016
Q1
$159K Sell
5,504
-274,244
-98% -$7.17M 0.02% 192
2015
Q4
$8.33M Hold
279,748
1.09% 22
2015
Q3
$8.33M Sell
279,748
-63,527
-19% -$2.07M 1.09% 22
2015
Q2
$12M Buy
343,275
+6,600
+2% +$233K 1.41% 9
2015
Q1
$11.9M Buy
336,675
+60,140
+22% +$2.03M 1.29% 10
2014
Q4
$9.58M Sell
276,535
-8,288
-3% -$292K 1.15% 19
2014
Q3
$10.1M Sell
284,823
-1,300
-0.5% -$49K 1.07% 21
2014
Q2
$11.5M Sell
286,123
-19,442
-6% -$746K 1.11% 15
2014
Q1
$12.2M Sell
305,565
-10,886
-3% -$392K 1.24% 24
2013
Q4
$10.4M Buy
+316,451
New +$9.87M 0.92% 43

Other funds holding DBD

Northpointe Capital's DBD Position: Q1 2018 in Review

Northpointe Capital sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2018, closing a stake of 213,554 shares — an estimated $3.49M sold.

Northpointe Capital first reported a position in DBD in Q4 2013 and held it in 12 quarters. The position peaked at $12.2M in Q1 2014. 246 funds tracked by Wall St. Rank hold DBD as of Q1 2018.

  • Northpointe Capital reported no remaining Diebold Nixdorf Incorporated position as of Q1 2018 after selling out during the quarter.
  • Northpointe Capital sold 213,554 Diebold Nixdorf Incorporated shares in Q1 2018, an estimated $3.49M.
  • Northpointe Capital first reported a position in Diebold Nixdorf Incorporated in Q4 2013 and held it in 12 quarters.
  • Northpointe Capital's Diebold Nixdorf Incorporated position peaked at $12.2M in Q1 2014.
  • 246 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2018.

Based on Northpointe Capital's 13F filing for Q1 2018, filed 11 Apr 2018.